Wird geladen...
Progression-free survival as a surrogate endpoint in advanced breast cancer
OBJECTIVES: Progression-free survival (PFS) has not been validated as a surrogate endpoint for overall survival (OS) for anthracycline (A) and taxane-based (T) chemotherapy in advanced breast cancer (ABC). Using trial-level, meta-analytic approaches, we evaluated PFS as a surrogate endpoint. METHODS...
Gespeichert in:
| Veröffentlicht in: | Int J Technol Assess Health Care |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744081/ https://ncbi.nlm.nih.gov/pubmed/18828930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0266462308080495 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|